Response | With Mitotane (n = 25) | Without Mitotane (n = 25) | Overall (N = 50) |
---|---|---|---|
Confirmed best overall response, n (%) | |||
Complete response | 0 | 0 | 0 |
Partial response | 2 (8.0) | 1 (4.0) | 3 (6.0) |
Stable disease | 10 (40.0) | 11 (44.0) | 21 (42.0) |
Progressive disease | 10 (40.0) | 13 (52.0) | 23 (46.0) |
Not evaluable | 3 (6.0) | 0 | 3 (6.0) |
ORR (95% CI), % | 8.0 (1.0–26.0) | 4.0 (0.1–20.4) | 6.0 (1.3–16.5) |
Disease control rate, % | 48.0 | 48.0 | 48.0 |